How COVID spurred drug repurposing research: A conversation with an FDA data scientist
SAS
MAY 17, 2023
Exploring the efficacy of existing drugs to treat COVID, an example of what's known as drug repurposing, was an intense focus for Qais Hatim, a Data Scientist at the US Food and Drug Administration [.] How COVID spurred drug repurposing research: A conversation with an FDA data scientist was published on SAS Voices by Steve Kearney
Let's personalize your content